Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Lutetium-177-edotreotide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ITM Presents COMPETE Phase 3 Dosimetry Data at SNMMI
    ITM Presents COMPETE Phase 3 Dosimetry Data at SNMMI

    01 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/01/3304102/0/en/itm-announces-phase-3-compete-data-supporting-single-timepoint-dosimetry-for-n-c-a-lu-edotreotide-itm-11-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-at-s.html

    GLOBENEWSWIRE
    01 Jun 2026
    Share Share
    ITM Secures $262.5m Debt Financing with Blue Owl Managed Funds
    ITM Secures $262.5m Debt Financing with Blue Owl Managed Funds

    27 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/27/3088398/0/en/ITM-Secures-Up-to-262-5m-in-Non-dilutive-Debt-Financing-with-Blue-Owl-Managed-Funds.html

    GLOBENEWSWIRE
    27 May 2025
    Share Share
    Novartis to buy radiology drug specialist Mariana for $1 billion
    Novartis to buy radiology drug specialist Mariana for $1 billion

    03 May 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-buy-radiology-specialist-mariana-oncology-1-billion-2024-05-02/

    REUTERS
    03 May 2024
    Share Share
    FDA Approves Novartis' Lutathera for Children With Neuroendocrine Cancers
    FDA Approves Novartis' Lutathera for Children With Neuroendocrine Cancers

    24 Apr 2024

    // FIERCE BIOTECH

    https://www.novartis.com/news/media-releases/novartis-radioligand-therapy-lutathera-fda-approved-first-medicine-specifically-pediatric-patients-gastroenteropancreatic-neuroendocrine-tumors

    FIERCE BIOTECH
    24 Apr 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.